Influence of the media on women taking antidepressants during pregnancy

Journal of Clinical Psychiatry

Volumn 70, Issue 9, 2009, Pages 1313-

  Einarson, Adrienne ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE;

BREAST FEEDING; CONGENITAL HEART MALFORMATION; DEPRESSION; DRUG EXPOSURE; FOOD AND DRUG ADMINISTRATION; HUMAN; INTERNET; LACTATION; MASS MEDIUM; MEDICAL DECISION MAKING; MENTAL DISEASE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RISK; SHORT SURVEY; TELEVISION; ADULT; ARTICLE; CARDIOVASCULAR MALFORMATION; CHEMICALLY INDUCED DISORDER; DOCTOR PATIENT RELATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; DRUG TOXICITY; FEMALE; METHODOLOGY; PREGNANCY COMPLICATION; PREVALENCE; STANDARD;

ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTIDEPRESSIVE AGENTS; CARDIOVASCULAR ABNORMALITIES; DEPRESSIVE DISORDER; DRUG INDUSTRY; DRUG INFORMATION SERVICES; DRUG TOXICITY; FEMALE; HUMANS; INTERNET; MASS MEDIA; PAROXETINE; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; PREGNANCY COMPLICATIONS; PREVALENCE;

EID: 70350458722     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09com05478     Document Type: Short Survey

References (21)

1. Grigoriadis S, Robinson GE. Gender issues in depression. Ann Clin Psychiatry. 2007;19(4):247-255. PubMed doi:10.1080/10401230701653294
2. Bennett HA, Einarson A, Taddio A, et al. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698-709. PubMed (Pubitemid 40459031)
3. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf. 2005;14(12):823-827. PubMed doi:10.1002/pds.1084 (Pubitemid 43056107)
4. Malm H, Klaukka T, Neuvonen PJ. Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol. 2005;106:1289-1296. PubMed (Pubitemid 41668948)
5. Modell J. Dear Healthcare Professional (December 2005 advisory letter). GlaxoSmithKline Web site. http://www.gsk.com/media/paroxetine/pregnancy-hcp- letter.pdf. Accessed July 28, 2008.
6. Kallen BA. Otterblad Olausson P. Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol. 2007;79(4):301-308. PubMed doi:10.1002/bdra.20327
7. Diav-Citrin O, Shechtman S, Weinbaum D, et al. Paroxetine and fluoxetine in pregnancy: a prospective, mulicentre, controlled, observational study. (abstract) Reprod Toxicol. 2005;20:459.
8. Important Prescribing Information (September 2005 advisory letter). Food and Drug Administration Web site. http://www.fda.gov/downloads/Safety/MedWatch/ SafetyInformation/ SafetyAlertsforHumanMedicalProducts/UCM164865.pdf. Accessed June 23, 2009.
9. Dillon JA. Important safety information on Paxil (paroxetine) and increased risk of cardiac defects following exposure during first trimester of pregnancy- for health professionals-GlaxoSmithKline Inc. Health Canada Web site. http://www.hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/-2005/paxil-4-hpc- cps-eng.php. Accessed June 23, 2009.
10. Einarson A, Schachtschneider AK, Halil R, et al. SSRIs and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy Childbirth. 2005;5:11. PubMed doi:10.1186/1471-2393-5-11 (Pubitemid 41460687)
11. ACOG committee on obstetric practice. Committee opinion no. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy. Obstet Gynecol. 2006;108:1601-1603. PubMed
12. Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry. 2008;165(6):749-752. PubMed doi:10.1176/appi.ajp. 2007.07060879 (Pubitemid 351810544)
13. Jetter A. Pregnant Pause. Vogue. 2009;(May):144, 148,232.
14. The Mulligan Law Firm is evaluating SSRI. Topix Web site. http://www.topix.net/content/prweb/2009/06 /the-mulligan-law-firm-is-evaluating- ssri-prozac-zoloft. Accessed June 5, 2009.
15. Lyszkiewicz DA, Gerichhausen S, Björnsdóttir I, et al. Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries. Pharm World Sci. 2001;23(2):76-81. PubMed doi:10.1023/A:1011227718654 (Pubitemid 32496282)
16. Compendium of Pharmaceuticals and Specialties 2009 (product monograph). Eli Lilly, revised June 2, 2008.
17. Louik C, Lin AE, Werler MM, et al. First-trimester use selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356(26):2675-2683. PubMed doi:10.1056/NEJMoa067407
18. Stigma of mental illness common among Canadians: report (based on the 8th Annual National Report Card on Health Care August 2008, Canadian Medical Association.). CBC News Web site Available at: http://www.cbc.ca/health/story/ 2008/08/15/mental-health.html and http://www.cma.ca/multimedia /CMA/Content-Images/Inside-cma/ Annual-Meeting/2008/GC-Bulletin/National-Report- Card-EN.pdf. Accessed October 7, 2008.
19. Alonso J, Buron A. Bruaerts R, et al. Association of perceived stigma and mood and anxiety disorders: results from the World Mental Health Surveys. Acta Psychiatr Scand. 2008;118(4):305-314. PubMed doi:10.1111/j.1600-0447.2008.01241. x
20. Griffiths KM, Christensen H, Jorm AF. Predictors of depression stigma. BMC Psychiatry. 2008;8:25. PubMed doi:10.1186/1471-244X-8-25
21. Wang J, Lai D. The relationship between mental health literacy, personal contacts and personal stigma against depression. J Affect Disord. 2008;110(1-2):191-196. PubMed doi:10.1016/j.jad.2008.01.005